We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Opioids Help Reduce Pain from Nerve Damage

By HospiMedica staff writers
Posted on 13 Apr 2003
A study has found that a morphine-like medication can significantly improve pain in patients suffering from chronic pain due to nervous system damage. More...
The study was published in the March 23, 2003, issue of The New England Journal of Medicine.

Some doctors are reluctant to prescribe opioids for patients with neuropathic pain because of concerns about ineffectiveness, addiction, and side effects. Animal studies have shown them to be relatively ineffective. In contrast, the new study found that the ability of an opioid called levorphanol to reduce neuropathic pain was similar to that of tricyclic antidepressants and the anticonvulsant gabapentin, two drugs commonly used for neuropathic pain. The study also showed that high-dose treatment provided greater pain reduction than a lower-dose regimen, and patients did not become tolerant of the drug.

However, researchers noted that more patients in the high-dose group dropped out of the study, complaining of a range of side effects, including restlessness, depression, and behavior changes. The study involved 81 patients, 59 of whom completed the eight-week therapy with levorphanol. All had severe and long-lasting pain.

"The study shows that opioids can be beneficial for relief of neuropathic pain but don't help everyone,” said lead author Michael Rowbotham, M.D., professor of clinical neurology and anesthesia at the University of California, San Francisco (UCSF, USA; www.ucsf.edu). "The benefits must be weighed against the drawbacks for each patient. Some may take a dose high enough to produce many side effects but still experience no relief of their pain.”




Related Links:
U. of California, San Francisco

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.